Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Join | Sign in
Home>Resources>Webcasts>This Webcast
  Webcasts
Miniaturization of AlphaLISA® Assays with the Labcyte® Echo® Liquid Handler and BMG PHERAstar® FS
Carl Peters, Ph.D., Senior Applications Scientist, BMG LABTECH and Bonnie Edwards, Applications Scientist, Labcyte Inc.
Date Posted: Friday, March 28, 2014
Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Related Content

Labcyte Receives $1 Million NCI Award
The award will be used to create an innovative process to detect cancer-related proteins in samples, with initial work in breast cancer detection.
Friday, November 22, 2013
Labcyte Announces Collaboration with AstraZeneca
Companies collaborate to use acoustic dispensing combined with mass spectrometry to greatly advance drug discovery applications.
Wednesday, September 25, 2013
Moving Liquids with Sound Helps Identify Drug Candidates that Traditional Lab Techniques Miss
A paper published by the journal PLOS ONE, May 1, 2013, demonstrates that the technique used to transfer compound solutions does indeed matter.
Friday, May 03, 2013
Labcyte Inc. Closes $5.3 Million Financing
Privately-held company with products that advance acoustic liquid handling closes a Series D financing.
Thursday, January 10, 2013
Labcyte and FIMM Announce a Collaboration Enabling “Real-Time” Science to Advance Personalized Medicine in Cancer Treatments
Collaboration expected to further the development of personalized medicine in cancer treatment.
Tuesday, January 08, 2013
Cancer Research Technology Selects the Labcyte Access™ Laboratory Workstation
Labcyte Access workstation to automate the production of assay-ready plates used in CRT's high-throughput cell based screening program
Monday, June 25, 2012
Labcyte Secures NIH Funding
The award of $196K from the National Cancer Institute will fund a collaborative cancer biomarker validation program with the Canary Center of Stanford University.
Wednesday, November 09, 2011
Labcyte Awarded 1st Patent in China
Labcyte has announced the grant of its first patent in China. Patent CN 101035681B describes how acoustic energy is used to assess the characteristics of any fluid in real time to optimize its transfer.
Thursday, September 30, 2010
Labcyte Awarded 40th US Patent
Patent number 7,717,544 describes how in real time acoustic energy is optimized to transfer a droplet of any fluid.
Wednesday, August 25, 2010
Labcyte Signs Bioscreen Instruments as Exclusive Distributor in India
Labcyte, the developer of acoustic liquid transfer, with systems in all top 10 pharmaceutical companies, today announced the selection of Bioscreen Instruments Pvt. Ltd. as its exclusive distributor in India.
Wednesday, September 23, 2009
Labcyte Awarded Second Japanese Patent
Patent covers the design for acoustics used for cell sorting and transfer.
Wednesday, August 19, 2009
Labcyte Echo Acoustic Liquid Handler an Essential Component of Pharmaceutical High-Throughput Screening
Recent issue of JBS emphasizes the importance of acoustic liquid handling in drug discovery.
Friday, August 07, 2009
Labcyte Awarded U. S. Patent Describing the Acoustic Transfer of Droplets into Small Openings Moving liquids with Sound™
The patent describes the acoustic transfer of fluid droplets into openings less than 300 microns in diameter.
Thursday, November 06, 2008
Portrait™ 630 Reagent Multi-Spotter Wins Technology Prize at MipTec 10th Anniversary Conference
The European Laboratory Robotics Interest Group has selected the Labcyte Portrait 630 reagent multi-spotter as the winner of its annual Technology Prize.
Tuesday, May 22, 2007
Labcyte Awarded 28th US Patent Describing Improved HTS Microplates
The US Patent 7,185, 969 describes microplates used in high-throughput screening that have low electrical resistance.
Thursday, March 15, 2007
Scientific News
Roll Up Your Screen and Stow it Away?
TAU researchers develop molecular backbone of super-slim, bendable digital displays.
Saccharin Shows Promise as Cancer Inhibitor
Researchers have found that the artificial sweetener can inhibit cancer cell growth.
Study Shows Quantose IR™ Measures Insulin Sensitivity Better
Results were recently published online by the Journal of Clinical Endocrinology & Metabolism.
Drinking Raw Milk Dramatically Increases Risk for Foodborne Illness, Analysis Finds
Researchers discourage the consumption of raw milk, especially by children, pregnant women and the elderly.
Immunomagnetic Assay On-a-Chip Captures, Analyzes Circulating Tumor Cells
Dartmouth researchers and bioengineers develop novel system to improve cancer treatment.
Genome Study Predicts DNA of the Whole of Iceland
Large genome databases are starting to reveal critical health information-even about people who have not contributed their DNA.
How the Human Immune System Keeps TB at Bay
Scientists create model of host, bacteria behavior in latent TB infection.
MDC Researchers Greatly Increase Precision of New Genome Editing Tool
“One of the hottest topics in science and an innovative field”.
‘Atomic Chicken-Wire’ Is Key To Faster DNA Sequencing
An unusual and very exciting form of carbon - that can be created by drawing on paper- looks to hold the key to real-time, high throughput DNA sequencing, a technique that would revolutionise medical research and testing.
The Switch That Might Tame The Most Aggressive Of Breast Cancers
Garvan researchers have found that so-called ‘triple-negative breast cancers’ are two distinct diseases that likely originate from different cell types. They have also found a gene that drives the aggressive disease, and hope to find a way to ‘switch it off’.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters